NYSE: LTHMLivent Corp Stock
$18.41+0.30 (+1.66%)
Updated Sep 29, 2023
LTHM Price
$18.41
Fair Value Price
N/A
Market Cap
$3.31B
52 Week Low
$16.94
52 Week High
$35.81
P/E
9.07x
P/B
2x
P/S
5.24x
PEG
N/A
Dividend Yield
N/A
Revenue
$940.30M
Earnings
$365.30M
Gross Margin
57.7%
Operating Margin
45.82%
Profit Margin
38.8%
Debt to Equity
0.38
Operating Cash Flow
$575M
Beta
1.63
Next Earnings
Oct 30, 2023
Ex-Dividend
N/A
Next Dividend
N/A
LTHM Overview
Livent Corporation manufactures and sells performance lithium based batteries, specialty polymer, and chemical synthesis applications in North America, Latin America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers lithium compounds for use in applications that have specific performance requirements, including battery-grade lithium hydroxide for use in high performance lithium-ion batteries; and butyllithium, which is used in the production of polymers and pharmaceutical products, as well as a range of specialty lithium compounds, including high purity lithium metal, which is used in the production of lightweight materials for aerospace applications and non-rechargeable batteries. It also provides lithium phosphate, pharmaceutical-grade lithium carbonate, high purity lithium chloride, and specialty organics; and lithium carbonate and lithium chloride for use as feedstock in the process of producing performance lithium compounds. The company was incorporated in 2018 and is headquartered in Philadelphia, Pennsylvania. Livent Corporation is a subsidiary of FMC Corporation.
Zen Score
–
Industry Average (40)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how LTHM scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
LTHM is forecast by analysts to be unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
LTHM is good value based on its earnings relative to its share price (9.07x), compared to the US market average (12.37x)
P/E vs Market Valuation
LTHM is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more LTHM due diligence checks available for Premium users.
Be the first to know about important LTHM news, forecast changes, insider trades & much more!
LTHM News
Valuation
LTHM price to earnings (PE)
For valuing profitable companies with steady earnings
Company
9.07x
Industry
25.13x
Market
12.37x
LTHM is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
LTHM is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
LTHM price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
2x
Industry
3.03x
LTHM is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
LTHM's financial health
Profit margin
Revenue
$235.8M
Net Income
$90.2M
Profit Margin
38.3%
LTHM's Earnings (EBIT) of $430.80M... subscribe to Premium to read more.
Interest Coverage Financials
LTHM's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$2.3B
Liabilities
$630.8M
Debt to equity
0.38
LTHM's short-term assets ($532.70M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
LTHM's short-term assets ($532.70M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
LTHM's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$78.7M
Investing
-$82.1M
Financing
-$21.5M
LTHM's operating cash flow ($575.10M)... subscribe to Premium to read more.
Debt Coverage Financials
LTHM vs Specialty Chemical Stocks
Livent Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.